Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H4N4 |
| Molecular Weight | 84.08 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=N)NC#N
InChI
InChIKey=QGBSISYHAICWAH-UHFFFAOYSA-N
InChI=1S/C2H4N4/c3-1-6-2(4)5/h(H4,4,5,6)
| Molecular Formula | C2H4N4 |
| Molecular Weight | 84.08 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Occupational allergic contact dermatitis caused by 2,4,6-tris-(dimethylaminomethyl)phenol, and review of sensitizing epoxy resin hardeners. | 1996 Dec |
|
| Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles. | 2005 Aug 22 |
|
| Neuroprotective effect of KR-31378, a novel potassium channel activator, on spinal cord ischemic injury in rabbits. | 2005 Nov-Dec |
|
| Bis(1-carbamimidoyl-2-ethyl-isourea)copper(II) bis-(perchlorate). | 2009 Sep 5 |
|
| Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase. | 2010 Dec 12 |
|
| Determination of impurities in medical products containing metformin hydrochloride. | 2010 Nov-Dec |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 07:02:02 GMT 2023
by
admin
on
Sat Dec 16 07:02:02 GMT 2023
|
| Record UNII |
M9B1R0C16H
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 176.170
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m4373
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
PRIMARY | Merck Index | ||
|
10005
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
PRIMARY | |||
|
C004711
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
PRIMARY | |||
|
207-312-8
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
PRIMARY | |||
|
2031
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
PRIMARY | |||
|
461-58-5
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
PRIMARY | |||
|
DTXSID1020354
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
PRIMARY | |||
|
M9B1R0C16H
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
PRIMARY | |||
|
Cyanoguanidine
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
PRIMARY | |||
|
1396310
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
PRIMARY | |||
|
147423
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
PRIMARY | |||
|
2126
Created by
admin on Sat Dec 16 07:02:02 GMT 2023 , Edited by admin on Sat Dec 16 07:02:02 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
